BACKGROUND: Disturbed vascular endothelial growth factor (VEGF) production during early heart morphogenesis causes endocardial cushion malformation, which results in congenital heart disease (CHD). We tested whether functional VEGF -460T/C and +405G/C polymorphisms that have an impact on VEGF levels were associated with CHD. METHODS: Dried blood samples were collected from 102 CHD children and 112 healthy control neonates. Genotyping was done with polymerase chain reaction-restriction fragment length polymorphism (VEGF +405G/C) and real-time polymerase chain reaction methods (VEGF -460T/C). RESULTS: VEGF -460C allele frequency was similar in control and CHD subjects. VEGF +405C allele was less prevalent in controls than in CHD subjects (0.21 vs 0.42, P < .001). Having VEGF +405C presented increased risk for CHD (odds ratio [OR] 1.72, 95% CI 1.32-2.26). VEGF -460CT/+405CC allele associations did not occur in controls but in CHD patients (0% vs 13%, OR 2.26, 95% CI 1.93-2.64), whereas -460CT/+405GG allele association was more prevalent in controls (32% vs 16%, OR 0.58, 95% CI 0.37-0.89). CONCLUSIONS: VEGF gene and allele associations may be associated with increased risk of CHD.
BACKGROUND: Disturbed vascular endothelial growth factor (VEGF) production during early heart morphogenesis causes endocardial cushion malformation, which results in congenital heart disease (CHD). We tested whether functional VEGF-460T/C and +405G/C polymorphisms that have an impact on VEGF levels were associated with CHD. METHODS: Dried blood samples were collected from 102 CHD children and 112 healthy control neonates. Genotyping was done with polymerase chain reaction-restriction fragment length polymorphism (VEGF+405G/C) and real-time polymerase chain reaction methods (VEGF-460T/C). RESULTS:VEGF -460C allele frequency was similar in control and CHD subjects. VEGF +405C allele was less prevalent in controls than in CHD subjects (0.21 vs 0.42, P < .001). Having VEGF +405C presented increased risk for CHD (odds ratio [OR] 1.72, 95% CI 1.32-2.26). VEGF -460CT/+405CC allele associations did not occur in controls but in CHD patients (0% vs 13%, OR 2.26, 95% CI 1.93-2.64), whereas -460CT/+405GG allele association was more prevalent in controls (32% vs 16%, OR 0.58, 95% CI 0.37-0.89). CONCLUSIONS:VEGF gene and allele associations may be associated with increased risk of CHD.
Authors: Kasper Lage; Steven C Greenway; Jill A Rosenfeld; Hiroko Wakimoto; Joshua M Gorham; Ayellet V Segrè; Amy E Roberts; Leslie B Smoot; William T Pu; Alexandre C Pereira; Sonia M Mesquita; Niels Tommerup; Søren Brunak; Blake C Ballif; Lisa G Shaffer; Patricia K Donahoe; Mark J Daly; Jonathan G Seidman; Christine E Seidman; Lars A Larsen Journal: Proc Natl Acad Sci U S A Date: 2012-08-16 Impact factor: 11.205
Authors: L A J Rammeloo; M C DeRuiter; N M van den Akker; L J Wisse; A C Gittenberger-de Groot Journal: Pediatr Cardiol Date: 2014-07-29 Impact factor: 1.655
Authors: Helen R Griffin; Darroch H Hall; Ana Topf; James Eden; A Graham Stuart; Jonathan Parsons; Ian Peart; John E Deanfield; John O'Sullivan; Sonya V Babu-Narayan; Michael A Gatzoulis; Frances A Bu'lock; Shoumo Bhattacharya; Jamie Bentham; Martin Farrall; Javier Granados Riveron; J David Brook; John Burn; Heather J Cordell; Judith A Goodship; Bernard Keavney Journal: PLoS One Date: 2009-03-24 Impact factor: 3.240
Authors: Mieke Delvaeye; Astrid De Vriese; Femke Zwerts; Inge Betz; Michael Moons; Monica Autiero; Edward M Conway Journal: BMC Dev Biol Date: 2009-03-26 Impact factor: 1.978